Suncoast Neuroscience Associates, Inc.

St. Petersburg, Florida 33713

1 studies enrolling now · 32 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Central Neuropathic Pain, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Cognition Disorders, Constipation, Diabetic Neuropathy, Dopamine Beta Hydroxylase Deficiency, Dyskinesia, Drug-Induced, Dyskinesias, Epilepsy, Complex Partial, Herpes Zoster

Studies at this site

• A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care — Recruiting now
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy — Stopped early
• A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis — Completed
• Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation — Completed
• Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease — Completed
• GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease — Completed
• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis — Completed
• Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease — Completed
• A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension — Stopped early
• A Study for Patients With Neurogenic Orthostatic Hypotension — Completed
• Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) — Stopped early
• An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease — Completed
• A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease — Completed
• Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment — Completed
• Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention — Completed
• Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials — Completed
• Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy — Completed
• Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) — Completed
• A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
• A Study of E2007 In Patients With Parkinson's Disease — Stopped early
• Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy — Completed
• Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia — Status unconfirmed
• E-STIM Trial: Comparing the Efficacy of the Empi Select TENS to a Control for the Treatment of Chronic Lower Back Pain — Status unconfirmed
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis — Completed
• Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain — Completed
• Evaluation of Galantamine in the Treatment of Alzheimer's Disease — Completed